Staphylococcus Haemolyticus
US-FDASourced from openFDA
GET
/api/v1/drug/staphylococcus-haemolyticusIndications
Sourced from openFDA- Rx Only*
Dosage & administration
Sourced from openFDAAdults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
486 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Diarrhoea336.8%
- 2Pain336.8%
- 3Headache306.2%
- 4Fatigue296.0%
- 5Nausea275.6%
- 6Arthralgia265.3%
- 7Dizziness255.1%
- 8Pain In Extremity214.3%
- 9Asthenia183.7%
- 10Abdominal Pain Upper173.5%
- 11Eye Pain173.5%
- 12Fall173.5%
- 13Gait Disturbance173.5%
- 14Muscle Spasms173.5%
- 15Dyspnoea163.3%
Literature
Recent PubMed references pinned to Staphylococcus Haemolyticus as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Genome-wide discovery and functional insights into novel sRNAs involved in responses to bioactive compounds in the emerging pathogen Staphylococcus haemolyticus.Journal of applied microbiology · 2026 · de Carvalho A, da Silva GC, Giambiagi-deMarval M, et al.PMID 41979513DOI 10.1093/jambio/lxag090
- Staphylococcus haemolyticus isolated from the Elaphurus davidianus: Pathogenicity and antimicrobial susceptibility profile.Research in veterinary science · 2026 · Meng Y, Han Q, Han M, et al.PMID 41762756DOI 10.1016/j.rvsc.2026.106116
- Whole genome sequence of multidrug-resistant Staphylococcus haemolyticus and Enterococcus faecalis isolates from public gymnasium equipment reveals evolving infection potential and resistance.PloS one · 2025 · Banerjee G, Banerjee PPMID 41160566DOI 10.1371/journal.pone.0324894
- Effect of phosphonium-based ionic liquid against mixed biofilm of Candida albicans and methicillin-resistant Staphylococcus haemolyticus isolated from hemodialysis catheter: assessment using confocal raman mapping and microscopic imaging.Biofouling · 2025 · Kendil W, Dergal F, Mediouni RM, et al.PMID 41158054DOI 10.1080/08927014.2025.2578762
- Detection of Heteroresistant Vancomycin-Intermediate Staphylococcus haemolyticus Among Blood Isolates.Microbial drug resistance (Larchmont, N.Y.) · 2025 · Manoharan M, Sistla S, Amberpet R, et al.PMID 41136204DOI 10.1177/10766294251389588
- Correlation between Biofilm Development and Antibiotic Resistance in Staphylococcus haemolyticus.Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina · 2025 · Mohammedali Y, Abed SPMID 41082738DOI 10.17392/1976-22-02
- Quorum-sensing control of sepsis in the coagulase-negative staphylococcal species Staphylococcus haemolyticus.Cell reports · 2025 · Cheung GYC, Da F, Fisher EL, et al.PMID 41004341DOI 10.1016/j.celrep.2025.116349
- Multilocus sequence type analysis of coagulase-negative staphylococci from the neonatal intensive care unit of a teaching hospital in Ghana.The Pan African medical journal · 2025 · Afeke I, Adu-Amankwaah J, Jamfaru I, et al.PMID 40950826DOI 10.11604/pamj.2025.51.59.45565
Clinical trials
The 2 most recently updated of 2 ClinicalTrials.gov registrations naming Staphylococcus Haemolyticus as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective EndocarditisRecruiting · Phase 3 · Interventional · 30 enrolled · University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)NCT06870409updated 2026-03-19
- Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and TrendsCompleted · Observational · 28 enrolled · Centre Hospitalier de Saint-DenisNCT07013864updated 2025-06-10
Frequently asked questions
- What is Staphylococcus Haemolyticus used for?
- According to FDA labeling, Staphylococcus Haemolyticus carries indications including: Rx Only*. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for
staphylococcus-haemolyticus is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.